Baidu
map

AACE 2016:左旋甲状腺素治疗甲状腺功能减退症或可改为每周一次用药

2016-05-29 Seven L MedSci原创

左旋甲状腺素从从每日一次切换到每周一次(剂量为每日剂量的7倍量)可有效治疗女性的甲状腺功能减退症,实现甲状腺功能。古尔加翁公园医院的Satish C. Wasoori博士和同事对40名25-55岁长期甲状腺功能减退(至少5年)的女性进行了研究,这些患者目前服用每日剂量的左旋甲状腺素,评估切换到每周一次(剂量为每日剂量的7倍量)对甲状腺功能减退症的疗效。参与者被分为两组:1组(n = 20),TSH

左旋甲状腺素从从每日一次切换到每周一次(剂量为每日剂量的7倍量)可有效治疗女性的甲状腺功能减退症,实现甲状腺功能。

古尔加翁公园医院的Satish C. Wasoori博士和同事对40名25-55岁长期甲状腺功能减退(至少5年)的女性进行了研究,这些患者目前服用每日剂量的左旋甲状腺素,评估切换到每周一次(剂量为每日剂量的7倍量)对甲状腺功能减退症的疗效。

参与者被分为两组:1组(n = 20),TSH≤4.12 µIU/L;2组(n = 20),TSH>4.12 µIU/L。所有患者均使用每日剂量的7倍量进行每周一次的治疗。

该研究以第84和168天时,1组正常甲功的维持比例和2组的达到正常甲功的比例为主要终点。使用TSH值评估甲状腺功能状态。

所有患者完成了研究,左旋甲状腺素的每周剂量的耐受性良好,没有参与者出现甲亢症状或间歇性的医源性甲亢。

数据显示,1组患者的空腹TSH水平没有发生显著变化,一切保持正常。此外,在0天、84天和168天时的空腹总胆固醇、高密度脂蛋白、低密度脂蛋白、甘油三酯、天门冬氨酸转氨酶、碱性磷酸酶或丙氨酸转移酶也没有显着差异。

2组空腹TSH水平显著变化(0天,16.44µIU/L;84天,4.98µIU/L;168天,4.05µIU/L),三碘甲状腺原氨酸(0天,82.79 ng/dL;84天,97 ng/dL;168天,100.25 ng/dL)和甲状腺素(0天,8.05µIU/L;84天,8.92µIU/L;168天,9.03µIU/L)也变化明显。

第68天,16名患者的甲状腺功能恢复正常;第168天,18名患者达到甲状腺机能正常 。代谢性疾病,如2型糖尿病高血压和肥胖症可能是未能达到正常的原因。

“我们的研究结果表明,每周一次的左旋甲状腺素替代治疗甲状腺功能减退症是安全有效的,“Wasoori 说,“在我们的研究中,青年和中年女性患者的耐受性很好,没有急诊治疗或甲状腺功能亢进症的症状。它可以成为年轻和中年女性甲状腺功能减退症的一线疗法。不过在未来还需要进一步的研究,包括大量的患者和更广泛的年龄组,以进一步验证该方法的有效性和安全性。”

原始出处:

Wasoori SC, Naik MH. Abstract #1182. Presented at: AACE Annual Scientific and Clinical Congress; May 25-29, 2016; Orlando, Fla.

Once-weekly levothyroxine effective hypothyroidism treatment in women.
Healio.May 28, 2016

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1655742, encodeId=a83b1655e4231, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Tue Jun 07 16:52:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699190, encodeId=ce6516991900f, content=<a href='/topic/show?id=1349166054' target=_blank style='color:#2F92EE;'>#AACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1660, encryptionId=1349166054, topicName=AACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca229920897, createdName=zgwhgch, createdTime=Mon Oct 03 15:52:00 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=127549, encodeId=bf8912e54935, content=这样的话就能减少服用次数,依从性会更好, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 15 14:33:00 CST 2016, time=2016-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88133, encodeId=5b9a881335f, content=好文章,得多学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Thu Jun 02 02:37:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456944, encodeId=11181456944b3, content=<a href='/topic/show?id=864d48113ea' target=_blank style='color:#2F92EE;'>#左旋甲状腺素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48113, encryptionId=864d48113ea, topicName=左旋甲状腺素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24a45820141, createdName=liuhuangbo, createdTime=Tue May 31 02:52:00 CST 2016, time=2016-05-31, status=1, ipAttribution=)]
    2016-06-07 shanyongle
  2. [GetPortalCommentsPageByObjectIdResponse(id=1655742, encodeId=a83b1655e4231, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Tue Jun 07 16:52:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699190, encodeId=ce6516991900f, content=<a href='/topic/show?id=1349166054' target=_blank style='color:#2F92EE;'>#AACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1660, encryptionId=1349166054, topicName=AACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca229920897, createdName=zgwhgch, createdTime=Mon Oct 03 15:52:00 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=127549, encodeId=bf8912e54935, content=这样的话就能减少服用次数,依从性会更好, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 15 14:33:00 CST 2016, time=2016-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88133, encodeId=5b9a881335f, content=好文章,得多学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Thu Jun 02 02:37:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456944, encodeId=11181456944b3, content=<a href='/topic/show?id=864d48113ea' target=_blank style='color:#2F92EE;'>#左旋甲状腺素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48113, encryptionId=864d48113ea, topicName=左旋甲状腺素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24a45820141, createdName=liuhuangbo, createdTime=Tue May 31 02:52:00 CST 2016, time=2016-05-31, status=1, ipAttribution=)]
    2016-10-03 zgwhgch
  3. [GetPortalCommentsPageByObjectIdResponse(id=1655742, encodeId=a83b1655e4231, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Tue Jun 07 16:52:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699190, encodeId=ce6516991900f, content=<a href='/topic/show?id=1349166054' target=_blank style='color:#2F92EE;'>#AACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1660, encryptionId=1349166054, topicName=AACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca229920897, createdName=zgwhgch, createdTime=Mon Oct 03 15:52:00 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=127549, encodeId=bf8912e54935, content=这样的话就能减少服用次数,依从性会更好, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 15 14:33:00 CST 2016, time=2016-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88133, encodeId=5b9a881335f, content=好文章,得多学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Thu Jun 02 02:37:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456944, encodeId=11181456944b3, content=<a href='/topic/show?id=864d48113ea' target=_blank style='color:#2F92EE;'>#左旋甲状腺素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48113, encryptionId=864d48113ea, topicName=左旋甲状腺素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24a45820141, createdName=liuhuangbo, createdTime=Tue May 31 02:52:00 CST 2016, time=2016-05-31, status=1, ipAttribution=)]
    2016-09-15 舒心和人

    这样的话就能减少服用次数,依从性会更好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1655742, encodeId=a83b1655e4231, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Tue Jun 07 16:52:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699190, encodeId=ce6516991900f, content=<a href='/topic/show?id=1349166054' target=_blank style='color:#2F92EE;'>#AACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1660, encryptionId=1349166054, topicName=AACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca229920897, createdName=zgwhgch, createdTime=Mon Oct 03 15:52:00 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=127549, encodeId=bf8912e54935, content=这样的话就能减少服用次数,依从性会更好, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 15 14:33:00 CST 2016, time=2016-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88133, encodeId=5b9a881335f, content=好文章,得多学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Thu Jun 02 02:37:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456944, encodeId=11181456944b3, content=<a href='/topic/show?id=864d48113ea' target=_blank style='color:#2F92EE;'>#左旋甲状腺素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48113, encryptionId=864d48113ea, topicName=左旋甲状腺素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24a45820141, createdName=liuhuangbo, createdTime=Tue May 31 02:52:00 CST 2016, time=2016-05-31, status=1, ipAttribution=)]
    2016-06-02 沉心多思

    好文章,得多学习了!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1655742, encodeId=a83b1655e4231, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Tue Jun 07 16:52:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699190, encodeId=ce6516991900f, content=<a href='/topic/show?id=1349166054' target=_blank style='color:#2F92EE;'>#AACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1660, encryptionId=1349166054, topicName=AACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca229920897, createdName=zgwhgch, createdTime=Mon Oct 03 15:52:00 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=127549, encodeId=bf8912e54935, content=这样的话就能减少服用次数,依从性会更好, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 15 14:33:00 CST 2016, time=2016-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88133, encodeId=5b9a881335f, content=好文章,得多学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Thu Jun 02 02:37:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456944, encodeId=11181456944b3, content=<a href='/topic/show?id=864d48113ea' target=_blank style='color:#2F92EE;'>#左旋甲状腺素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48113, encryptionId=864d48113ea, topicName=左旋甲状腺素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24a45820141, createdName=liuhuangbo, createdTime=Tue May 31 02:52:00 CST 2016, time=2016-05-31, status=1, ipAttribution=)]

相关资讯

2012 ATA 成人甲状腺功能减退症新版临床实践指南发布

 近日,美国甲状腺协会(American Thyroid Association ,ATA)和美国内分泌医师协会(American Association of Clinical Endocrinologists ,AACE)共同制定了新的甲状腺机能减退症的治疗和诊断循证指南。该指南在线发表于9月12日《甲状腺》杂志(Thyroid)。 ATA和AACE工作小组回顾了医学文献和现行治

Baidu
map
Baidu
map
Baidu
map